The widespread, multisystemic nature of these effects in the Csf2-/- mouse model, in which immunological defects are expressed at the whole-animal level, suggests aPAP is manifested by a state of systemic functional GM-CSF deficiency rather than simply an isolated pulmonary syndrome. Here, CSF2 is linked to autoimmune pulmonary alveolar proteinosis.